Aquestive Therapeutics
AQST
AQST
54 hedge funds and large institutions have $31.5M invested in Aquestive Therapeutics in 2023 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 18 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
85% more capital invested
Capital invested by funds: $17M → $31.5M (+$14.5M)
54% more funds holding
Funds holding: 35 → 54 (+19)
6.54% more ownership
Funds ownership: 27.58% → 34.11% (+6.5%)
Holders
54
Holding in Top 10
2
Calls
$179K
Puts
$18K
Top Buyers
| 1 | +$1.91M | |
| 2 | +$1.17M | |
| 3 | +$666K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$449K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$411K |
Top Sellers
| 1 | -$98.4K | |
| 2 | -$38.1K | |
| 3 | -$26.7K | |
| 4 |
VF
Virtu Financial
New York
|
-$15K |
| 5 |
FAIM
Financial Advocates Investment Management
Olympia,
Washington
|
-$8.25K |